Gevo, Inc.
GEVO · XNASCIK 1392380fmd_0S0A627XM3HD66C4SVSFD6QX4RManufacturing · Industrial Organic ChemicalsTemplate: Standard
Coverage: Jan 01, 2006 to Sep 30, 2026, 70 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 27 | 28 | 33 | 24 | 6 | 1 | 1 | 17 | 17 | 161 |
| Rental revenue | – | – | – | 0 | 0 | 0 | – | – | – | – |
| Cost of revenue | 37 | 38 | 42 | 37 | 15 | – | – | – | – | – |
| Gross profit | (10) | (11) | (9) | (12) | (9) | (11) | – | – | – | – |
| Research and development | 5 | 5 | 5 | 4 | 4 | 7 | 7 | 7 | 6 | 5 |
| Selling, general and administrative | 9 | 7 | 8 | 10 | 11 | 25 | – | – | – | – |
| Total operating expenses | 14 | 13 | 13 | 14 | 17 | 49 | – | – | – | – |
| Operating income | (24) | (23) | (22) | (26) | (27) | (60) | (103) | (82) | (91) | (20) |
| Interest expense | 8 | 3 | 3 | 3 | 2 | 0 | 1 | 2 | 4 | 18 |
| Interest and investment income | – | – | – | 0 | 0 | 1 | 4 | 19 | 16 | 5 |
| Other non-operating income (expense) | (13) | (1) | (6) | (2) | (13) | 1 | 5 | 16 | 12 | (12) |
| Income tax expense | – | – | 0 | 0 | 0 | – | – | – | – | – |
| Net income from continuing operations | – | – | – | – | – | – | – | – | – | – |
| Net income | (37) | (25) | (28) | (29) | (40) | (59) | (98) | (66) | (79) | (34) |
| Net income to common shareholders | – | – | – | – | – | (59) | (98) | (66) | (79) | – |